MONTELEONE, FABRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 3.584
EU - Europa 269
AS - Asia 189
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
SA - Sud America 2
Totale 4.048
Nazione #
US - Stati Uniti d'America 3.583
KR - Corea 76
IT - Italia 63
IE - Irlanda 60
SG - Singapore 56
CN - Cina 49
DE - Germania 47
UA - Ucraina 35
GB - Regno Unito 13
FR - Francia 11
PL - Polonia 11
RU - Federazione Russa 11
SE - Svezia 8
FI - Finlandia 6
AU - Australia 2
BR - Brasile 2
EU - Europa 2
GR - Grecia 2
CA - Canada 1
CZ - Repubblica Ceca 1
ES - Italia 1
HK - Hong Kong 1
IN - India 1
IR - Iran 1
JP - Giappone 1
LK - Sri Lanka 1
MY - Malesia 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 4.048
Città #
Wilmington 1.113
Houston 984
Woodbridge 648
Fairfield 130
Chandler 129
Ann Arbor 66
New York 64
Ashburn 58
Dublin 49
Seattle 49
Cambridge 47
Singapore 47
Dearborn 40
Medford 28
Jacksonville 22
Rome 16
Lawrence 14
Roebling 14
Beijing 13
Kraków 11
Santa Clara 9
Moscow 8
Norwalk 8
Zhengzhou 7
San Diego 6
Philadelphia 5
San Jose 5
Palo Alto 4
Redwood City 4
Seoul 4
Shanghai 4
Detroit 3
Frankfurt am Main 3
Hefei 3
Kunming 3
Nanjing 3
Turin 3
Verona 3
Arosio 2
Camino al Tagliamento 2
Chongqing 2
Del Norte 2
Guangzhou 2
Helsinki 2
Lissone 2
Menlo Park 2
Milan 2
Munich 2
Nanchang 2
Parma 2
Pavia 2
Piove di Sacco 2
São Paulo 2
Ardea 1
Bangkok 1
Brno 1
Buffalo 1
Caserta 1
Central 1
Chengdu 1
Chiswick 1
Colombo 1
Fuzhou 1
Haikou 1
Hangzhou 1
Huzhou 1
Jinan 1
Jinhua 1
Kilburn 1
Kuala Lumpur 1
Lappeenranta 1
Lodi 1
London 1
Mcallen 1
Mountain View 1
Novokuznetsk 1
Nürnberg 1
Paris 1
Pescara 1
Pomezia 1
Pullach im Isartal 1
Pune 1
Redmond 1
Sabz 1
Saint Paul 1
Saint Petersburg 1
Stanmore 1
Strasbourg 1
Sydney 1
Toronto 1
Wakefield 1
Xian 1
Totale 3.696
Nome #
Functional connectivity changes within specific networks parallel the clinical evolution of multiple sclerosis 420
Fingolimod reduces the clinical expression of active demyelinating lesions in MS 385
Nerve growth factor is elevated in the CSF of patients with multiple sclerosis and central neuropathic pain 365
Treatment options to reduce disease activity after natalizumab: paradoxical effects of corticosteroids 351
Reversible hyporegenerative anemia during natalizumab treatment 341
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 299
Fingolimod reduces the clinical expression of active demyelinating lesions in MS 294
Safety, tolerability and effectiveness of dimethyl fumarate in multiple sclerosis: an independent, multicenter, real-world study 285
Oral D-Aspartate enhances synaptic plasticity reserve in progressive multiple sclerosis 260
TRPV1 channels regulate cortical excitability in humans 260
Enhancing brain plasticity to contrast clinical progression in MS: a pilot study assessing the safety and efficacy of D-Aspartate 253
Exit strategies for “needle fatigue” in multiple sclerosis: a propensity score-matched comparison study 163
Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis 154
The influence of physiotherapy intervention on patients with multiple sclerosis–related spasticity treated with nabiximols (THC:CBD oromucosal spray) 145
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis 41
Delayed treatment of MS is associated with high CSF levels of IL-6 and IL-8 and worse future disease course 34
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study 24
The influence of physiotherapy intervention on patients with multiple sclerosis-related spasticity treated with nabiximols (THC:CBD oromucosal spray) 21
CSF tau levels influence cortical plasticity in Alzheimer's disease patients 13
null 3
Totale 4.111
Categoria #
all - tutte 9.281
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.281


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.067 0 0 82 109 91 134 131 108 130 104 83 95
2020/2021800 88 101 88 103 80 96 86 95 15 22 14 12
2021/2022139 10 12 0 4 3 17 11 8 5 19 17 33
2022/2023345 25 24 50 67 22 58 28 17 32 2 12 8
2023/2024109 21 4 5 10 8 33 2 8 2 0 0 16
2024/202585 16 69 0 0 0 0 0 0 0 0 0 0
Totale 4.111